Outsourced drug discovery market to top $68bn in 2028

By Maggie Lynch

The global drug discovery market is expected to reach $68bn in 2028, according to a Visiongain report, with revenue gains driven by flexibility, agility, and the ability to innovate, says Evotec executive.

(Image: iStock/travellinglight)

Evotec completes Cyprotex acquisition

By Melissa Fassbender

Evotec AG has completed its previously announced acquisition of the preclinical contract research organization (CRO), Cyrotex.

Sanofi signs CRO Evotec to €250m, five-year research partnership

Sanofi signs CRO Evotec to €250m, five-year research partnership

By Zachary Brennan

The strategic partnership comes with Sanofi providing €250m to Evotec, including €40m upfront, as part of efforts to discover new drug candidates, including in the area of oncology, and specifically at Sanofi’s R&D site in Toulouse, France.

Evotec Q3 down from 2003

Evotec Q3 down from 2003

German biotech company Evotec OAI posted decreased third quarterly
revenues of €16.1 million, down 26 per cent compared to 2003.
Evotec's performance reflects the difficult operating environment
for companies supplying drug discovery...


Follow us


View more


Featured Suppliers